You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

OFORTA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Oforta patents expire, and what generic alternatives are available?

Oforta is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in OFORTA is fludarabine phosphate. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fludarabine phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Oforta

A generic version of OFORTA was approved as fludarabine phosphate by HIKMA on August 28th, 2003.

  Try a Trial

Drug patent expirations by year for OFORTA
Recent Clinical Trials for OFORTA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Jonsson Comprehensive Cancer CenterPhase 1
Bristol-Myers SquibbPhase 1
Stand Up To CancerPhase 1

See all OFORTA clinical trials

US Patents and Regulatory Information for OFORTA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us OFORTA fludarabine phosphate TABLET;ORAL 022273-001 Dec 18, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for OFORTA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us OFORTA fludarabine phosphate TABLET;ORAL 022273-001 Dec 18, 2008 ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us OFORTA fludarabine phosphate TABLET;ORAL 022273-001 Dec 18, 2008 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for OFORTA

See the table below for patents covering OFORTA around the world.

Country Patent Number Title Estimated Expiration
Russian Federation 2004122479 ⤷  Try a Trial
Israel 162555 ULTRAPURE ORAL FLUDARA FORMULATION WITH A FAST RELEASING ACTIVE SUBSTANCE ⤷  Try a Trial
Norway 20043063 ⤷  Try a Trial
Denmark 1455760 ⤷  Try a Trial
Germany 59807096 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 03053418 ⤷  Try a Trial
Poland 341659 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.